These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9. Plumb JA; Gerritsen M; Workman P Br J Cancer; 1994 Dec; 70(6):1136-43. PubMed ID: 7526885 [TBL] [Abstract][Full Text] [Related]
36. Antioxidant response induced by serum withdrawal protects HL-60 cells against inhibition of NAD(P)H:quinone oxidoreductase 1. Gómez-Díaz C; Bello RI; López-Lluch G; Forthoffer N; Navas P; Villalba JM Biofactors; 2003; 18(1-4):219-28. PubMed ID: 14695937 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells. Nolan KA; Scott KA; Barnes J; Doncaster J; Whitehead RC; Stratford IJ Biochem Pharmacol; 2010 Oct; 80(7):977-81. PubMed ID: 20599803 [TBL] [Abstract][Full Text] [Related]
38. Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ. Nemeikaite-Ceniene A; Dringeliene A; Sarlauskas J; Cenas N Acta Biochim Pol; 2005; 52(4):937-41. PubMed ID: 15940348 [TBL] [Abstract][Full Text] [Related]
39. Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo. Kapinya KJ; Harms U; Harms C; Blei K; Katchanov J; Dirnagl U; Hörtnagl H J Neurochem; 2003 Mar; 84(5):1028-39. PubMed ID: 12603827 [TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction. Tudor G; Alley M; Nelson CM; Huang R; Covell DG; Gutierrez P; Sausville EA Anticancer Drugs; 2005 Apr; 16(4):381-91. PubMed ID: 15746574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]